IRLA · IRulya Therapeutics Inc. · Documents
$36.92
+2.47 (+7.17%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Factoring in these potential cash payments, based on its current operating plan, the Company believes that its cash and cash equivalents balance will not be sufficient to fund operations and capital expenditures for at least the twelve months following the issuance of these unaudited condensed consolidated financial statements. Accordingly, the Company concluded that substantial doubt about the Company's ability to continue as a going concern continues to exist within one year after the date these financial statements are available to be issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$35.04M
Shares
1.02M
Volume · Oct 20
166.31K
Avg daily vol (3M)
29.7K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2022-07-22 | 2022-07-20 | |
| 8-K | — | 2022-06-10 | 2022-06-08 | |
| DEFA14A | — | 2022-05-25 | — | |
| 8-K | — | 2022-05-20 | 2022-05-19 | |
| 8-K | — | 2022-05-12 | 2022-05-07 | |
| 8-K | — | 2022-05-10 | 2022-05-09 | |
| 10-Q | — | 2022-05-10 | 2022-03-31 | |
| 8-K | — | 2022-05-02 | 2022-04-26 | |
| DEF 14A | — | 2022-04-27 | 2022-06-08 | |
| DEFA14A | — | 2022-04-27 | — | |
| 8-K | — | 2022-03-15 | 2022-03-14 | |
| 10-K | — | 2022-03-01 | 2021-12-31 | |
| 8-K | — | 2022-02-02 | 2022-01-28 | |
| 8-K | — | 2022-01-26 | 2022-01-25 | |
| 8-K | — | 2021-12-23 | — | |
| 10-Q | — | 2021-10-29 | 2021-09-30 | |
| 8-K | — | 2021-10-26 | — | |
| 10-Q | — | 2021-08-06 | 2021-06-30 | |
| 8-K | — | 2021-06-21 | 2021-06-16 | |
| 8-K | — | 2021-05-18 | 2021-05-13 | |
| 10-Q | — | 2021-05-06 | 2021-03-31 | |
| DEF 14A | — | 2021-04-30 | 2021-06-16 | |
| DEFA14A | — | 2021-04-30 | — | |
| 10-K | — | 2021-03-01 | 2020-12-31 | |
| 8-K | — | 2021-02-16 | 2021-02-12 | |
| 8-K | — | 2021-02-10 | 2021-02-09 | |
| 8-K | — | 2021-01-26 | — | |
| 8-K | — | 2021-01-25 | 2021-01-19 | |
| 8-K | — | 2020-12-04 | — | |
| 10-Q | — | 2020-11-12 | 2020-09-30 | |
| 10-Q | — | 2020-08-14 | 2020-06-30 | |
| 8-K | — | 2020-06-10 | 2020-06-08 | |
| S-3ASR | — | 2020-06-01 | — | |
| 8-K | — | 2020-05-21 | 2020-05-18 | |
| 10-Q | — | 2020-05-12 | 2020-03-31 | |
| 8-K | — | 2020-05-12 | — | |
| 8-K | — | 2020-04-30 | 2020-04-27 | |
| DEF 14A | — | 2020-04-22 | 2020-06-08 | |
| DEFA14A | — | 2020-04-22 | — | |
| S-1 | — | 2020-04-07 | — | |
| 8-K | — | 2020-03-17 | — | |
| 10-K | — | 2020-03-16 | 2019-12-31 | |
| 8-K | — | 2020-02-06 | 2020-02-05 |
Showing 101–143 of 143 filings